Establishment of an International Collaborative Network for N-of-1 Trials and Single-Case Designs

• Published in: Contemporary clinical trials communications Vol. 23; p. 100826
• Main Authors: Nikles, Jane, Onghena, Patrick, Vlaeyen, Johan W.S., Wicksell, Rikard K., Simons, Laura E., McGree, James M., McDonald, Suzanne
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.09.2021; Elsevier
• Subjects: Clinical trials; Clinical trials network; Medicin och hälsovetenskap; N-of-1 trials; Network; Single Case Experimental Design; Clinical trials; Single Case Experimental Design; Clinical trials network; N-of-1 trials; Network
• ISSN: 2451-8654; 2451-8654
• DOI: 10.1016/j.conctc.2021.100826

In this article we briefly examine the unique features of Single-Case Designs (SCDs) (studies in a single participant), their history and current trends, and real-world clinical applications. The International Collaborative Network for N-of-1 Trials and Single-Case Designs (ICN) is a formal collaborative network for individuals with an interest in SCDs. The ICN was established in 2017 to support the SCD scientific community and provide opportunities for collaboration, a global communication channel, resource sharing and knowledge exchange. In May 2021, there were more than 420 members in 31 countries. A member survey was undertaken in 2019 to identify priorities for the ICN for the following few years. This article outlines the key priorities identified and the ICN's progress to date in these key areas including network activities (developing a communications strategy to increase awareness, collecting/sharing a comprehensive set of resources, guidelines and tips, and incorporating the consumer perspective) and scientific activities (writing position papers and guest editing special journal issues, exploring key stakeholder perspectives about SCDs, and working to streamline ethical approval processes for SCDs). The ICN provides a practical means to engage with this methodology through membership. We encourage clinicians, researchers, industry, and healthcare consumers to learn more about and conduct SCDs, and to join us in our mission of using SCDs to improve health outcomes for individuals and populations.